Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TCF-001 TRACK (Target Rare Cancer Knowledge) Study

NCT04504604 is registered in ClinicalTrials.gov with TargetCancer Foundation as lead sponsor.

NCT NCT04504604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04504604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TCF-001 TRACK (Target Rare Cancer Knowledge) Study
Lead sponsor
TargetCancer Foundation
Phase
Not applicable
Overall status
Recruiting
Start date
October 1, 2020
Completion date
December 31, 2028
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of unknown primary site, cholangiocarcinoma, rare cancers